Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
01 Oct 2024
// Jonathan Stempel REUTERS
https://www.reuters.com/legal/amgen-must-face-lawsuit-claiming-it-hid-107-billion-tax-bill-2024-09-30/
25 Sep 2024
// STATNEWS
https://www.statnews.com/2024/09/24/amgen-success-trials-eczema-rocatinlimab-myasthenia-gravis-uplizna-competition-remains-stiff/
24 Sep 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/regeneron-loses-bid-block-amgens-eylea-biosimilar-entering-market
23 Sep 2024
// REUTERS
https://www.reuters.com/legal/litigation/amgen-gets-early-win-regeneron-lawsuit-over-eylea-biosimilar-2024-09-23/
16 Sep 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/cro/amgen-and-merck-become-first-industry-partners-academic-clinical-trial-diversity-initiative
13 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amgen-to-present-data-from-multiple-early-stage-clinical-trials-at-esmo-2024-302247205.html
Inspections and registrations
ABOUT THIS PAGE
Amgen Inc is a supplier offers 9 products (APIs, Excipients or Intermediates).
Find a price of INTRAVENOUS SOLUTION STABILIZER (IVSS) bulk with DMF offered by Amgen Inc
Find a price of AMG 191 CELL LINE DEVELOPMENT bulk with DMF offered by Amgen Inc
Find a price of AMG 282 DRUG SUBSTANCE bulk with DMF offered by Amgen Inc
Find a price of AMG 191 DRUG SUBSTANCE bulk with DMF offered by Amgen Inc
Find a price of AMG 157 (TEZEPELUMAB) PHASE 3 CMC AMENDMENT (DRUG SUBSTANCE AND DRUG PRODUCT) bulk with DMF offered by Amgen Inc
Find a price of AMG 191 DRUG PRODUCT bulk with DMF offered by Amgen Inc
Find a price of BULK PURIFIED MURINE MONOCLONAL ANTIBODY (ABX-CBL) TO BLAST CELLS bulk offered by Amgen Inc
Find a price of HUMAN MONOCLONAL ANTIBODY (ABX-EGF) TO EPIDERMAL GROWTH FACTOR RECEPTOR bulk offered by Amgen Inc
Find a price of HUMAN MONOCLONAL ANTIBODY (MDX-015)(SP2/0,- AG14 CELLS, MEDAREX) TO IL15 bulk offered by Amgen Inc
LOOKING FOR A SUPPLIER?